Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinomaAmin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
Science (New York, N.Y.)|March 16, 2019
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fateAbhishek A Chakraborty, Tuomas Laukka, Matti Myllykoski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
Nature Communications|April 10, 2019
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosisYilong Zou, Michael J Palte, Amy A Deik, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinomaPrathyusha Konda, Cary N Weiss, Yantong Cui, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Pageof 25